Intranasal corticosteroids and the eye: from negative ocular effects to clinical efficacy as a class effect.
Bielory
Leonard
L
Division of Allergy, Immunology, and Rheumatology, Departments of Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, USA. bielory@umdnj.edu
D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003233:Conjunctivitis, Allergic / Q000150:complications / Q000188:drug therapy*; D005123:Eye / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D015201:Meta-Analysis as Topic; D012221:Rhinitis, Allergic, Perennial / Q000150:complications / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists